Relay Therapeutics, Inc. (RLAY)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 7.08 |
| Open | 8.71 |
| Bid | 7.02 x 200 |
| Ask | 7.05 x 200 |
| Day's Range | 6.79 - 8.71 |
| 52 Week Range | 5.70 - 13.32 |
| Volume | |
| Avg. Volume | 1,247,875 |
| Market Cap | 934.504M |
| Beta (5Y Monthly) | 1.63 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.63 |
| Earnings Date | May 02, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 23.05 |
Simply Wall St.Relay Therapeutics First Quarter 2024 Earnings: Beats Expectations
Relay Therapeutics ( NASDAQ:RLAY ) First Quarter 2024 Results Key Financial Results Revenue: US$10.0m (up by US$9.78m...
GuruFocus.comRelay Therapeutics Outperforms Revenue Expectations in Q1 2024
Despite Net Loss, Relay Therapeutics Reports Significant Revenue Growth and Robust Pipeline Progress
ZacksRelay Therapeutics, Inc. (RLAY) Reports Q1 Loss, Tops Revenue Estimates
Relay Therapeutics (RLAY) delivered earnings and revenue surprises of 11.43% and 2,905.11%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.